Discover the complete record of transactions filed by Leavitt Chase C.. Director active across 1 companies, notably Oncternal Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €40k. The latest transaction was filed on 27 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.